Skip to main content
  • 29 Accesses

Zusammenfassung

Unterteilung. Die menschlichen Atemwege werden funktionell in leitende und gasaustauschende Atemwege (Alveolen) eingeteilt. Die leitenden Luftwege warden anatomisch in Nase und/oder Mund, Pharynx, Larynx und Tracheobronchialbaum unterteilt. Dieses komplizierte, verästelte Röhrensystem kann auf verschiedene Art und Weise weiter unterteilt werden (Abb. 97). Wichtig ist, sich nicht auf einen einzigen Teil des Systems zu konzentrieren, sondern die Luftwege als Einheit von der Nase bis zu den Alveolen zu betrachten. Die Form des Lumens sagt etwas über die spezialisierte Aufgabe des jeweiligen Teils der Luftwege aus, und der Charakter des Wandaufbaus ist für Atemwegsobstruktion und -erkrankung von Bedeutung (Abb. 98).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aas K (1972) The biochemical and immunological basis of bronchial asthma. Charles C Thomas, Springfield, pp 1–238

    Google Scholar 

  2. Al Bazzaz F, Grillo H, Kazemi H (1975) Response to exercise in upper airway obstruction. Am Rev Respir Dis 111: 631–40

    Google Scholar 

  3. Azarnoff DL (ed)(1975) Symposium on steroid therapy. WB Saunders, Philadelphia, pp 1–340

    Google Scholar 

  4. Baxter JD, Forsham PH (1972) Tissue effects of glucocorticoids. Am J Med 53: 573–7

    Article  PubMed  CAS  Google Scholar 

  5. Bernstein IL, Siegel SC, Brandon ML et al. (1972) A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy. J Allergy Clin Immunol 50: 235–45

    Article  PubMed  CAS  Google Scholar 

  6. Bernstein IL (1981) Cromolyn sodium in the treatment of asthma: changing concepts. J Allergy Clin Immunol 68: 247 - 53

    Article  PubMed  CAS  Google Scholar 

  7. Bernstein IL (1983) Asthma in adults: diagnosis and treatment. In: Middleton Jr E, Reed CE, Ellis EF (eds) Allergy: principles and practice, 2nd ed. CVMosby, Saint Louis, pp 901–34

    Google Scholar 

  8. Blackwell G, Carnuccio R, Dirosa M, Flower RJ, Parente L, Percio P (1980) Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 287: 147–9

    Article  PubMed  CAS  Google Scholar 

  9. Booij-Noord H, Orie NGM, De Vries K (1971) Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. J Allergy Clin Immunol 48: 344–8

    Article  PubMed  CAS  Google Scholar 

  10. Borum P, Mygind N (1980) Inhibition of the immediate allergic reaction in the nose by the beta2 adreno-stimulant, fenoterol. J Allergy Clin Immunol 66: 25–32

    Article  PubMed  CAS  Google Scholar 

  11. Britton MG, Collins JV, Brown D, Fairhurst NPA, Lambert RG (1976) High-dose corticosteroids in severe acute asthma. Br J Med 2: 73–4

    Article  CAS  Google Scholar 

  12. Bürge PS (1982) The effects of corticosteroids on immediate asthmatic reaction. Eur J Respir Dis 63 (suppl 122): 163–6

    Google Scholar 

  13. Clark TJH (1977) Corticosteroids. In: ClarkTJH, Godfrey S Asthma. Chapman and Hall, London, pp 286–302

    Google Scholar 

  14. Clark TJH, Mygind N, Selros O (eds) (1982) International symposium on corticosteroid treatment in allergic airway diseases. Eur J Respir Dis 63 (Suppl 122): 1–278

    Google Scholar 

  15. Dunnill MS (1978) The pathology of asthma. In: Middleton Jr E, Reed CE, Ellis EF (eds) Allergy: principles and practice. CVMosby, Saint Louis, pp 678–86

    Google Scholar 

  16. Ellis EF (1978) Theophylline and derivates. In: Middleton Jr E, Reed CE, Ellis EF (eds) Allergy: principles and practice. CVMosby, Saint Louis, pp 434–453

    Google Scholar 

  17. Ellul-Michalef R (1982) The acute effects of corticosteroids in bronchial asthma. Eur J Respir Dis 63 (Suppl 122): 118–25

    Google Scholar 

  18. Gallager JT, Kent PW, Passatore M, Phipps RJ, Richardson PS (1975) The composition of tracheal mucus, and the nervous control of its secretion in the cat. Proc R Soc R 192: 46–76

    Google Scholar 

  19. Gold WM (1973) Cholinergic pharmacology in asthma. In: Austen KF, Lichtenstein LM (eds) Asthma: physiology, immunopharmacology, and treatment. Academic Press, New York, pp 169–84

    Google Scholar 

  20. Grieco MH (1972) Double blind crossover study of cromolyn sodium inhibition of aerosol antigen. Chest 61: 432–8

    Article  PubMed  CAS  Google Scholar 

  21. Griffin MP, MacDonald N, McFadden ER (1983) Short- and long-term effects of cromolyn sodium on the airway reactivity of asthmatics. J Allergy Clin Immunol 71: 331–8

    Article  PubMed  CAS  Google Scholar 

  22. Groth S, Dirksen H, Mygind N (1984) Intranasal fenoterol in asthmatics: an alternative route of administration. J Allergy Clin Immunol 74: 536–9

    Article  PubMed  CAS  Google Scholar 

  23. Hartley JPR, Charles TJ, Seaton A (1977) Betamethasone valerate inhalation and exerciseinduced asthma. Br J Dis Chest 71: 253–8

    Article  PubMed  CAS  Google Scholar 

  24. Hendeles L, Weinberger M, Wyatt R (1978) Guide to oral theophylline therapy for the treatment of chronic asthma. Am J Dis Child 132: 876–80

    PubMed  CAS  Google Scholar 

  25. Hetzel MR, Clark RJH (1976) Comparison of intravenous and aerosol salbutamol. Br Med J 2: 919

    Article  PubMed  CAS  Google Scholar 

  26. Hirata F, Schiffman E,Venkata Subramanian K, Salomon D, Axelrod J (1980)Aphospholipase

    Google Scholar 

  27. A2 inhibitory protein in rabbit neutrophils induced by glucorticoids. Proc Natl Acad Sci USA 77: 2533–6

    Google Scholar 

  28. Hofbrand BI (ed) (1975) The place of parasympatholytic drugs in the management of chronic obstructive airway diseases. Postgrad Med J 51 (Suppl 7): 1–161

    Google Scholar 

  29. Hogg JC, Pare PD, Boucher R, Michoud M-C, Guerzon G, Moroz L (1977) Pathologic abnormalities in asthma. In: Lichtenstein LM, Austen FK (eds) Asthma: physiology, immunopharmacology and treatment. Academic Press, New York, pp 1–19

    Google Scholar 

  30. Holzman MJ, Sheller JR, Dimeo M, Nadel JA, Boushey HA. (1980) Effect of ganglionic blockade on bronchial reactivity in atopic subjects. Am Rev Respir Dis 122: 17–25

    Google Scholar 

  31. Honsinger RW, Silverstein D, Van Arsdal PP (1972) The eosinophil and allergy: Why? J Allergy Clin Immunol 49: 142–8

    Article  PubMed  Google Scholar 

  32. Jenne JW (1975) Rationale for methylxanthines in asthma. In: Stein M (ed) New directions in asthma. American College of Chest Physicians, Park Ridge, 111., pp 391–413

    Google Scholar 

  33. Kay AB, Lee TH (1983) Mediators of hypersensitivity in exercise-induced asthma. Eur J Respir Dis 64 (Suppl 128): 237–41

    Google Scholar 

  34. Laursen LC, Weeke B (1983) Enprofylline - effects of a new xanthine derivative in asthmatic patients. Allergy 38: 75–9

    Article  PubMed  CAS  Google Scholar 

  35. Lieberman P, Patterson R, Kunske R (1972) Complications of long-term steroid therapy for asthma. J Allergy Clin Immunol 49: 329–36

    Article  PubMed  CAS  Google Scholar 

  36. Lightbody IM, Ingram CG, Legge JS, Johnson RN (1978) Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis. Br J Dis Chest 72: 181–6

    Article  PubMed  CAS  Google Scholar 

  37. McAllen M (1970) Long term side effects of corticosteroids. Respiration 27 (Suppl): 250–9

    Article  PubMed  Google Scholar 

  38. McCarthy D, Milic-Emili J (1973) Closing volume in asymptomatic asthma. Am Rev Respr Dis 107: 559–70

    CAS  Google Scholar 

  39. Mossberg B, Strandberg K, Camner P (1977) Stimulatory effect of beta-adrenergic drugs on mucociliary transport. Scand J Respir Dis suppl 101: 71–8

    PubMed  CAS  Google Scholar 

  40. Mygind N, Wihl J-A (1977) Scanning electron microscopy of a bacterial infection of the human nose. Br J Dis Chest 71: 259–67

    Article  PubMed  CAS  Google Scholar 

  41. Mygind N, Clark TJH (eds) (1980) Topical steroid treatment for asthma and rhinitis. Bailliere Tindall, London, pp 1–188

    Google Scholar 

  42. Nadel JA (1973) Neurophysiologic aspects of asthma. In: Austen KF, Lichtenstein LM (eds) Asthma: physiology, immunopharmacology, and treatment. Academic Press, New York, pp 29–38

    Google Scholar 

  43. Netter FH (1979) Respiratory system. The CIBA Collection of Medical Illustrations, volume 7. CIBA Pharmaceutical, New Jersey, pp 1–328

    Google Scholar 

  44. Pakes GE, Brogden RN, Heel RC, Speight TM, Avery GS (1980) Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs 20: 237–66

    Article  PubMed  CAS  Google Scholar 

  45. Pepys J, Hutchroft BJ (1975) Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis 112: 928–59

    Google Scholar 

  46. Preliminary Report of the Brompton Hospital/Medical Research Council Collaborative Trial (1974) Double-blind trial comparing two dosage schedules of beclomethasone dipropionate in the treatment of chronic bronchial asthma. Lancet 2: 303–7

    Google Scholar 

  47. Schatz M (1984) Asthma and pregnancy. In: Dawson A, Simon RA (eds) The practical management of asthma. Gruñe & Stratton, Orlando, pp 195–211

    Google Scholar 

  48. Sheppard D, Nadel JA, Boushey HA (1981) Inhibition of sulfur dioxyde-induced bronchoconstriction by disodium cromoglycate in asthmatic subjects. Am Rev Respir Dis 124: 257–9

    PubMed  CAS  Google Scholar 

  49. Sleigh MA (1977) The nature and action of respiratory tract cilia. In: Brain JD, Proctor DF, Reid LM (eds) Respiratory defense mechanisms, part I. Marcel Dekker, New York, p 247–88

    Google Scholar 

  50. Smyllie HC, Conolly CK (1968) Incidence of serious complications of corticosteroid therapy in respiratory disease. Thorax 23: 571–81

    Article  PubMed  CAS  Google Scholar 

  51. Svedmyr K (1981) Beta2-adrenoceptor stimulants and theophylline in asthma therapy. Eur J Respir Dis 62 (Suppl 116): 1–48

    Google Scholar 

  52. Svedmyr N (1982) Pharmacological effects of glucorticosteroids in the airways. Eur J Respir 63 (Suppl 122): 48–53

    Google Scholar 

  53. Svedmyr N (1983) Methylxanthines in asthma. Agents Actions, (Suppl 13 ): 83–103

    CAS  Google Scholar 

  54. Svedmyr N (1983) Airway hyperreactivity: clinical treatment with drugs. In: Simonsson BG (ed) Airway hyperreactivity. Eur J Respir Dis 64 (Suppl 131 ): 313–29

    Google Scholar 

  55. Svedmyr N (1984) Is beta-adrenoceptor sensitivity a limiting factor in asthma therapy? In: Morley J (ed) Beta-adrenoceptors in asthma. Academic Press, London, pp 181–99

    Google Scholar 

  56. Svedmyr N (1985) Intravenous sympathomimetic drugs in acute asthma. In: Weiss EB, Segal MS, Stein M (eds) Status asthmaticus, 2nd ed. University Park Press, Baltimore, chapter 55

    Google Scholar 

  57. Svedmyr N, Simonsson BG (1978) Drugs in the treatment of asthma. PharmacolTher B 3: 397–440

    PubMed  CAS  Google Scholar 

  58. Thiringer G, Svedmyr N (1970) A comparison of the effects of isoprenaline and salbutamol on different beta-receptors in asthmatic patients. Postgrad Med J, ( Suppl 47 ): 44–6

    Google Scholar 

  59. Thiringer G, Svedmyr N (1976) Comparison of infused and inhaled terbutaline in patients with asthma. Scand J Respir Dis 57: 17–24

    PubMed  CAS  Google Scholar 

  60. Thompson P, Friedman M (1977) Intramuscular salbutamol in treatment of acute exacerbations of childhood asthma. Arch Dis Child 52: 551–4

    Article  PubMed  CAS  Google Scholar 

  61. Vale JR, Molgaard F (eds) (1983) Fenoterol inhalation powder. Eur J Respir Dis 64 (Suppl 130): 1–72

    Google Scholar 

  62. Venter JC, Fraser CM, Nelson HS, Middleton Jr E (1983) Adrenergic agents. In: Middleton Jr E, Reed CE, Ellis EF (eds) Allergy: principles and practice, 2nd ed. CVMosby, Saint Louis, pp 503–33

    Google Scholar 

  63. Weinberger M (1984) The pharmacology and therapeutic use of theophylline. J Allergy Clin Immunol 73: 525–44

    Article  PubMed  CAS  Google Scholar 

  64. Widdicombe J, Davies A (1983) Respiratory physiology. Edward Arnold, London, pp 1–118

    Google Scholar 

  65. Woodcock AA, Johnson MAA, Geddes DM (1983) Theophylline prescribing, serum concentrations, and toxocity. Lancet 2: 610–3

    Article  PubMed  CAS  Google Scholar 

  66. Woolcock A J (1977) Inhaled drugs in the prevention of asthma. Am Rev Respir Dis 115:191–4

    Google Scholar 

  67. Zanjanian MH (1980) Expectorants and antitussive agents: are they helpful? Ann Allergy 44: 290–5

    PubMed  CAS  Google Scholar 

  68. Ziment I (1978) Respiratory pharmacology and therapeutics. WB Saunders

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this chapter

Cite this chapter

Mygind, N. (1989). Asthma. In: Grundriß der Allergologie. Steinkopff. https://doi.org/10.1007/978-3-642-72426-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72426-8_5

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0764-7

  • Online ISBN: 978-3-642-72426-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics